J&J Medical Connect
  • Home/
  • Products/
  • LAZCLUZE™/
  • Current page
LAZCLUZE™

(lazertinib)

+ Save link

LAZCLUZE™ (lazertinib)

  • icon-pdfFull Prescribing Information (English)
  • icon-pdfFull Prescribing Information (Spanish)

 

Pivotal clinical trial publications

MARIPOSA

  • Cho BC, Lu S, Felip E, et al. Amivantamab plus lazertinib in previously untreated EGFR-mutated advanced NSCLC [published online ahead of print June 26, 2024]. N Engl J Med. 2024. doi:10.1056/nejmoa2403614.
  • Cho BC, Lu S, Felip E, et al. Supplementary Appendix for: Amivantamab plus lazertinib in previously untreated EGFR-mutated advanced NSCLC [published online ahead of print June 26, 2024]. N Engl J Med. 2024. doi:10.1056/nejmoa2403614.

 

Plain language summaries of pivotal clinical trials

MARIPOSA

  • Cho BC, Felip E, Hayashi H, et al. MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer. Future Oncol. 2024.18(6):639-647.  

 

 

  • Report an adverse eventchevronright
  • Report a product quality complaintchevronright

Contact J&J Medical Connect for your medical inquiries

  • Chat live
  • SearchMedical information
  • Connect with my MSL
  • Call me now
  • Email
  • Call 1-800-526-7736
  • Live video
Loading Common Footer...
Loading Common Footer...

Medical inquiries

Connect with my medical science liaison

Connect with my medical science liaison

Chat live

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Email your inquiry

Call 1-800-526-7736

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Live video

Available Monday - Friday 9AM - 4:30PM ET

Endchat
Chat live